Comparison:Article Title: Transcriptomes of Prostate Cancer with <i>TMPRSS2:ERG</i> and Other ETS Fusions
Article Snippet: The study by Berglund and colleagues (14), which additionally included tumors from the GenomeDX GRID database but did not separate ERG and non-ERG ETS fusions, also identified differences by ETS status thatwere not apparent in our analysis but that have strong support from other lines of evidence, such as androgen signaling (34, 35), cholesterol homeostasis, and estrogen response (36).
Article Title: Revolution of Alzheimer Precision Neurology: Passageway of Systems Biology and Neurophysiology
Article Snippet: Based on the gene expression profiles generated by GenomeDx Biosciences Decipher Genomics Resource Information Database (Decipher GRID ® ), a recent analysis showed that the genomic signature PAM50, normally applied to breast cancer patients to determine their risk of reappearance, can be used in prostate cancer as well for predicting which individual may take advantage from early initiation of post-operative androgen deprivation therapy (ADT), thus delivering a potential clinical tool to customize the treatment of prostate cancer.
Article Title: SCIENTIFIC PROGRAM OF 36TH WORLD CONGRESS OF ENDOUROLOGY PROGRAM BOOK
Article Snippet: D Gearman, B Linder, D Elliott United States MP3-21 A randomized prospective comparison of single incision mini-sling with transobrutator tape in women with stress urinary incontinence : 12 months follow-up results M Gul, MA Diri Turkey MP3-22 Laproscopic Burch colposuspension in failed midurethral sling procedures P Kasaraneni, N H.K., P S.M.L., T Javali India Friday 21 September Moderated Poster Session 4: Imaging & Image Guided Therapy: New Therapies 10:00–12:00 MP4-1 Predictors of PSMA (FOLH1) expression in the GenomeDx GRID database CD Bahler, M Johnson, J Alter, M Green, M Koch United States MP4-2 Phase 2 clinical trial in prostate cancer evaluating 68Ga-PSMA-11 detection for preoperative planning CD Bahler, M Green, G Hutchins, L Cheng, J Fletcher, M Koch United States MP4-3 Transperineal electromagnetically-guided MR/US fusion guided biopsy demonstrates comparable prostate cancer detection rates to transrectal fusion guided biopsy when utilizing the same platform S Doppalapudi, H Anastos, J Winoker, P Shukla, S Cumarasamy, J Sfakianos, M Carrick, CJ Knauer, B Taouli, SC Lewis, J Schwartz, A Rastinehad United States MP4-4 Does it matter who perform multiparametric magnetic resonance imaging directed cognitive prostate biopsy to detect prostate cancer?
Imaging:Article Title: Transcriptomes of Prostate Cancer with <i>TMPRSS2:ERG</i> and Other ETS Fusions
Article Snippet: The study by Berglund and colleagues (14), which additionally included tumors from the GenomeDX GRID database but did not separate ERG and non-ERG ETS fusions, also identified differences by ETS status thatwere not apparent in our analysis but that have strong support from other lines of evidence, such as androgen signaling (34, 35), cholesterol homeostasis, and estrogen response (36).
Article Title: Revolution of Alzheimer Precision Neurology: Passageway of Systems Biology and Neurophysiology
Article Snippet: Based on the gene expression profiles generated by GenomeDx Biosciences Decipher Genomics Resource Information Database (Decipher GRID ® ), a recent analysis showed that the genomic signature PAM50, normally applied to breast cancer patients to determine their risk of reappearance, can be used in prostate cancer as well for predicting which individual may take advantage from early initiation of post-operative androgen deprivation therapy (ADT), thus delivering a potential clinical tool to customize the treatment of prostate cancer.
Article Title: SCIENTIFIC PROGRAM OF 36TH WORLD CONGRESS OF ENDOUROLOGY PROGRAM BOOK
Article Snippet: D Gearman, B Linder, D Elliott United States MP3-21 A randomized prospective comparison of single incision mini-sling with transobrutator tape in women with stress urinary incontinence : 12 months follow-up results M Gul, MA Diri Turkey MP3-22 Laproscopic Burch colposuspension in failed midurethral sling procedures P Kasaraneni, N H.K., P S.M.L., T Javali India Friday 21 September Moderated Poster Session 4: Imaging & Image Guided Therapy: New Therapies 10:00–12:00 MP4-1 Predictors of PSMA (FOLH1) expression in the GenomeDx GRID database CD Bahler, M Johnson, J Alter, M Green, M Koch United States MP4-2 Phase 2 clinical trial in prostate cancer evaluating 68Ga-PSMA-11 detection for preoperative planning CD Bahler, M Green, G Hutchins, L Cheng, J Fletcher, M Koch United States MP4-3 Transperineal electromagnetically-guided MR/US fusion guided biopsy demonstrates comparable prostate cancer detection rates to transrectal fusion guided biopsy when utilizing the same platform S Doppalapudi, H Anastos, J Winoker, P Shukla, S Cumarasamy, J Sfakianos, M Carrick, CJ Knauer, B Taouli, SC Lewis, J Schwartz, A Rastinehad United States MP4-4 Does it matter who perform multiparametric magnetic resonance imaging directed cognitive prostate biopsy to detect prostate cancer?
Expressing:Article Title: Transcriptomes of Prostate Cancer with <i>TMPRSS2:ERG</i> and Other ETS Fusions
Article Snippet: The study by Berglund and colleagues (14), which additionally included tumors from the GenomeDX GRID database but did not separate ERG and non-ERG ETS fusions, also identified differences by ETS status thatwere not apparent in our analysis but that have strong support from other lines of evidence, such as androgen signaling (34, 35), cholesterol homeostasis, and estrogen response (36).
Article Title: Revolution of Alzheimer Precision Neurology: Passageway of Systems Biology and Neurophysiology
Article Snippet: Based on the gene expression profiles generated by GenomeDx Biosciences Decipher Genomics Resource Information Database (Decipher GRID ® ), a recent analysis showed that the genomic signature PAM50, normally applied to breast cancer patients to determine their risk of reappearance, can be used in prostate cancer as well for predicting which individual may take advantage from early initiation of post-operative androgen deprivation therapy (ADT), thus delivering a potential clinical tool to customize the treatment of prostate cancer.
Article Title: SCIENTIFIC PROGRAM OF 36TH WORLD CONGRESS OF ENDOUROLOGY PROGRAM BOOK
Article Snippet: D Gearman, B Linder, D Elliott United States MP3-21 A randomized prospective comparison of single incision mini-sling with transobrutator tape in women with stress urinary incontinence : 12 months follow-up results M Gul, MA Diri Turkey MP3-22 Laproscopic Burch colposuspension in failed midurethral sling procedures P Kasaraneni, N H.K., P S.M.L., T Javali India Friday 21 September Moderated Poster Session 4: Imaging & Image Guided Therapy: New Therapies 10:00–12:00 MP4-1 Predictors of PSMA (FOLH1) expression in the GenomeDx GRID database CD Bahler, M Johnson, J Alter, M Green, M Koch United States MP4-2 Phase 2 clinical trial in prostate cancer evaluating 68Ga-PSMA-11 detection for preoperative planning CD Bahler, M Green, G Hutchins, L Cheng, J Fletcher, M Koch United States MP4-3 Transperineal electromagnetically-guided MR/US fusion guided biopsy demonstrates comparable prostate cancer detection rates to transrectal fusion guided biopsy when utilizing the same platform S Doppalapudi, H Anastos, J Winoker, P Shukla, S Cumarasamy, J Sfakianos, M Carrick, CJ Knauer, B Taouli, SC Lewis, J Schwartz, A Rastinehad United States MP4-4 Does it matter who perform multiparametric magnetic resonance imaging directed cognitive prostate biopsy to detect prostate cancer?
Magnetic Resonance Imaging:Article Title: Transcriptomes of Prostate Cancer with <i>TMPRSS2:ERG</i> and Other ETS Fusions
Article Snippet: The study by Berglund and colleagues (14), which additionally included tumors from the GenomeDX GRID database but did not separate ERG and non-ERG ETS fusions, also identified differences by ETS status thatwere not apparent in our analysis but that have strong support from other lines of evidence, such as androgen signaling (34, 35), cholesterol homeostasis, and estrogen response (36).
Article Title: Revolution of Alzheimer Precision Neurology: Passageway of Systems Biology and Neurophysiology
Article Snippet: Based on the gene expression profiles generated by GenomeDx Biosciences Decipher Genomics Resource Information Database (Decipher GRID ® ), a recent analysis showed that the genomic signature PAM50, normally applied to breast cancer patients to determine their risk of reappearance, can be used in prostate cancer as well for predicting which individual may take advantage from early initiation of post-operative androgen deprivation therapy (ADT), thus delivering a potential clinical tool to customize the treatment of prostate cancer.
Article Title: SCIENTIFIC PROGRAM OF 36TH WORLD CONGRESS OF ENDOUROLOGY PROGRAM BOOK
Article Snippet: D Gearman, B Linder, D Elliott United States MP3-21 A randomized prospective comparison of single incision mini-sling with transobrutator tape in women with stress urinary incontinence : 12 months follow-up results M Gul, MA Diri Turkey MP3-22 Laproscopic Burch colposuspension in failed midurethral sling procedures P Kasaraneni, N H.K., P S.M.L., T Javali India Friday 21 September Moderated Poster Session 4: Imaging & Image Guided Therapy: New Therapies 10:00–12:00 MP4-1 Predictors of PSMA (FOLH1) expression in the GenomeDx GRID database CD Bahler, M Johnson, J Alter, M Green, M Koch United States MP4-2 Phase 2 clinical trial in prostate cancer evaluating 68Ga-PSMA-11 detection for preoperative planning CD Bahler, M Green, G Hutchins, L Cheng, J Fletcher, M Koch United States MP4-3 Transperineal electromagnetically-guided MR/US fusion guided biopsy demonstrates comparable prostate cancer detection rates to transrectal fusion guided biopsy when utilizing the same platform S Doppalapudi, H Anastos, J Winoker, P Shukla, S Cumarasamy, J Sfakianos, M Carrick, CJ Knauer, B Taouli, SC Lewis, J Schwartz, A Rastinehad United States MP4-4 Does it matter who perform multiparametric magnetic resonance imaging directed cognitive prostate biopsy to detect prostate cancer?
Biomarker Discovery:Article Title: Transcriptomes of Prostate Cancer with <i>TMPRSS2:ERG</i> and Other ETS Fusions
Article Snippet: The study by Berglund and colleagues (14), which additionally included tumors from the GenomeDX GRID database but did not separate ERG and non-ERG ETS fusions, also identified differences by ETS status thatwere not apparent in our analysis but that have strong support from other lines of evidence, such as androgen signaling (34, 35), cholesterol homeostasis, and estrogen response (36).
Article Title: Revolution of Alzheimer Precision Neurology: Passageway of Systems Biology and Neurophysiology
Article Snippet: Based on the gene expression profiles generated by GenomeDx Biosciences Decipher Genomics Resource Information Database (Decipher GRID ® ), a recent analysis showed that the genomic signature PAM50, normally applied to breast cancer patients to determine their risk of reappearance, can be used in prostate cancer as well for predicting which individual may take advantage from early initiation of post-operative androgen deprivation therapy (ADT), thus delivering a potential clinical tool to customize the treatment of prostate cancer.
Article Title: SCIENTIFIC PROGRAM OF 36TH WORLD CONGRESS OF ENDOUROLOGY PROGRAM BOOK
Article Snippet: D Gearman, B Linder, D Elliott United States MP3-21 A randomized prospective comparison of single incision mini-sling with transobrutator tape in women with stress urinary incontinence : 12 months follow-up results M Gul, MA Diri Turkey MP3-22 Laproscopic Burch colposuspension in failed midurethral sling procedures P Kasaraneni, N H.K., P S.M.L., T Javali India Friday 21 September Moderated Poster Session 4: Imaging & Image Guided Therapy: New Therapies 10:00–12:00 MP4-1 Predictors of PSMA (FOLH1) expression in the GenomeDx GRID database CD Bahler, M Johnson, J Alter, M Green, M Koch United States MP4-2 Phase 2 clinical trial in prostate cancer evaluating 68Ga-PSMA-11 detection for preoperative planning CD Bahler, M Green, G Hutchins, L Cheng, J Fletcher, M Koch United States MP4-3 Transperineal electromagnetically-guided MR/US fusion guided biopsy demonstrates comparable prostate cancer detection rates to transrectal fusion guided biopsy when utilizing the same platform S Doppalapudi, H Anastos, J Winoker, P Shukla, S Cumarasamy, J Sfakianos, M Carrick, CJ Knauer, B Taouli, SC Lewis, J Schwartz, A Rastinehad United States MP4-4 Does it matter who perform multiparametric magnetic resonance imaging directed cognitive prostate biopsy to detect prostate cancer?
Gene Expression:Article Title: Transcriptomes of Prostate Cancer with <i>TMPRSS2:ERG</i> and Other ETS Fusions
Article Snippet: The study by Berglund and colleagues (14), which additionally included tumors from the GenomeDX GRID database but did not separate ERG and non-ERG ETS fusions, also identified differences by ETS status thatwere not apparent in our analysis but that have strong support from other lines of evidence, such as androgen signaling (34, 35), cholesterol homeostasis, and estrogen response (36).
Article Title: Revolution of Alzheimer Precision Neurology: Passageway of Systems Biology and Neurophysiology
Article Snippet: Based on the gene expression profiles generated by GenomeDx Biosciences Decipher Genomics Resource Information Database (Decipher GRID ® ), a recent analysis showed that the genomic signature PAM50, normally applied to breast cancer patients to determine their risk of reappearance, can be used in prostate cancer as well for predicting which individual may take advantage from early initiation of post-operative androgen deprivation therapy (ADT), thus delivering a potential clinical tool to customize the treatment of prostate cancer.
Article Title: SCIENTIFIC PROGRAM OF 36TH WORLD CONGRESS OF ENDOUROLOGY PROGRAM BOOK
Article Snippet: D Gearman, B Linder, D Elliott United States MP3-21 A randomized prospective comparison of single incision mini-sling with transobrutator tape in women with stress urinary incontinence : 12 months follow-up results M Gul, MA Diri Turkey MP3-22 Laproscopic Burch colposuspension in failed midurethral sling procedures P Kasaraneni, N H.K., P S.M.L., T Javali India Friday 21 September Moderated Poster Session 4: Imaging & Image Guided Therapy: New Therapies 10:00–12:00 MP4-1 Predictors of PSMA (FOLH1) expression in the GenomeDx GRID database CD Bahler, M Johnson, J Alter, M Green, M Koch United States MP4-2 Phase 2 clinical trial in prostate cancer evaluating 68Ga-PSMA-11 detection for preoperative planning CD Bahler, M Green, G Hutchins, L Cheng, J Fletcher, M Koch United States MP4-3 Transperineal electromagnetically-guided MR/US fusion guided biopsy demonstrates comparable prostate cancer detection rates to transrectal fusion guided biopsy when utilizing the same platform S Doppalapudi, H Anastos, J Winoker, P Shukla, S Cumarasamy, J Sfakianos, M Carrick, CJ Knauer, B Taouli, SC Lewis, J Schwartz, A Rastinehad United States MP4-4 Does it matter who perform multiparametric magnetic resonance imaging directed cognitive prostate biopsy to detect prostate cancer?
Generated:Article Title: Transcriptomes of Prostate Cancer with <i>TMPRSS2:ERG</i> and Other ETS Fusions
Article Snippet: The study by Berglund and colleagues (14), which additionally included tumors from the GenomeDX GRID database but did not separate ERG and non-ERG ETS fusions, also identified differences by ETS status thatwere not apparent in our analysis but that have strong support from other lines of evidence, such as androgen signaling (34, 35), cholesterol homeostasis, and estrogen response (36).
Article Title: Revolution of Alzheimer Precision Neurology: Passageway of Systems Biology and Neurophysiology
Article Snippet: Based on the gene expression profiles generated by GenomeDx Biosciences Decipher Genomics Resource Information Database (Decipher GRID ® ), a recent analysis showed that the genomic signature PAM50, normally applied to breast cancer patients to determine their risk of reappearance, can be used in prostate cancer as well for predicting which individual may take advantage from early initiation of post-operative androgen deprivation therapy (ADT), thus delivering a potential clinical tool to customize the treatment of prostate cancer.
Article Title: SCIENTIFIC PROGRAM OF 36TH WORLD CONGRESS OF ENDOUROLOGY PROGRAM BOOK
Article Snippet: D Gearman, B Linder, D Elliott United States MP3-21 A randomized prospective comparison of single incision mini-sling with transobrutator tape in women with stress urinary incontinence : 12 months follow-up results M Gul, MA Diri Turkey MP3-22 Laproscopic Burch colposuspension in failed midurethral sling procedures P Kasaraneni, N H.K., P S.M.L., T Javali India Friday 21 September Moderated Poster Session 4: Imaging & Image Guided Therapy: New Therapies 10:00–12:00 MP4-1 Predictors of PSMA (FOLH1) expression in the GenomeDx GRID database CD Bahler, M Johnson, J Alter, M Green, M Koch United States MP4-2 Phase 2 clinical trial in prostate cancer evaluating 68Ga-PSMA-11 detection for preoperative planning CD Bahler, M Green, G Hutchins, L Cheng, J Fletcher, M Koch United States MP4-3 Transperineal electromagnetically-guided MR/US fusion guided biopsy demonstrates comparable prostate cancer detection rates to transrectal fusion guided biopsy when utilizing the same platform S Doppalapudi, H Anastos, J Winoker, P Shukla, S Cumarasamy, J Sfakianos, M Carrick, CJ Knauer, B Taouli, SC Lewis, J Schwartz, A Rastinehad United States MP4-4 Does it matter who perform multiparametric magnetic resonance imaging directed cognitive prostate biopsy to detect prostate cancer?
|
